Literature DB >> 7129640

Effect of C-reactive protein on the complement-mediated stimulated of human neutrophils by Streptococcus pneumoniae serotypes 3 and 6.

C Mold, K M Edwards, H Gewurz.   

Abstract

C-reactive protein (CRP) has long been known to appear in the sera of individuals with inflammatory processes, but its role in host defense against bacterial infection is unclear. We have recently demonstrated that CRP in the presence of the classical complement pathway markedly enhances the opsonization of Streptococcus pneumoniae serotype 27 by polymorphonuclear leukocytes (Edwards et al., J. Immunol. 128:2493-2496). In this report we have extended these studies to characterize the role of CRP in the opsonization of other S. pneumoniae serotypes. Two clinically important serotypes, 3 and 6, were tested along with the nonpathogenic rough strain R36a. All strains were found to bind radiolabeled CRP in the presence of calcium and to activate the classical complement pathway in normal human serum. However, the opsonophagocytic response of polymorphonuclear leukocytes to the strains, measured by chemiluminescence, was quite different. In contrast to the marked enhancement by CRP of the chemiluminescent response to serotype 27 in normal human serum, CRP had no effect on the opsonization of serotype 6 or R36a and inhibited opsonization of serotype 3 in normal serum. In serum from a hypogammaglobulinemic patient, CRP enhanced the lowered chemiluminescent response to serotype 3 and 6 organisms but did not restore the response to normal. The greater opsonic effect of CRP on serotype 27 may be related to the ability of CRP to bind to the capsule as well as to the cell wall of this serotype or to differences in the amount of CRP bound to the different strains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7129640      PMCID: PMC347636          DOI: 10.1128/iai.37.3.987-992.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide.

Authors:  J E Volanakis; M H Kaplan
Journal:  Proc Soc Exp Biol Med       Date:  1971-02

2.  Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria.

Authors:  C O Kindmark
Journal:  Clin Exp Immunol       Date:  1971-06       Impact factor: 4.330

3.  Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation.

Authors:  I M Goldstein; M Brai; A G Osler; G Weissmann
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Studies of human C-reactive protein in an in vitro phagocytic system.

Authors:  R C Williams; P G Quie
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

6.  Affinity labeling of a phosphorylcholine binding mouse myeloma protein.

Authors:  B Chesebro; H Metzger
Journal:  Biochemistry       Date:  1972-02-29       Impact factor: 3.162

7.  Degradation of a pneumococcal type-specific polysaccharide with exposure of group-specificity.

Authors:  J D Higginbotham; M Heidelberger; E C Gotschlich
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

8.  Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis.

Authors:  R F Mortensen; A P Osmand; T F Lint; H Gewurz
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

9.  Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera.

Authors:  J Siegel; R Rent; H Gewurz
Journal:  J Exp Med       Date:  1974-09-01       Impact factor: 14.307

10.  Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations.

Authors:  J Siegel; A P Osmand; M F Wilson; H Gewurz
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

2.  Evaluation of a C-reactive protein latex agglutination detection test with sera from patients with sexually transmitted diseases.

Authors:  W O Schalla; R J Arko; S E Thompson
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

3.  Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.

Authors:  Constantine Bitsaktsis; Bibiana V Iglesias; Ying Li; Jesus Colino; Clifford M Snapper; Susan K Hollingshead; Giang Pham; Diane R Gosselin; Edmund J Gosselin
Journal:  Infect Immun       Date:  2011-12-12       Impact factor: 3.441

Review 4.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

5.  Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae.

Authors:  D S Chudwin; S G Artrip; A Korenblit; G Schiffman; S Rao
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

6.  Stress-induced differences in primary and secondary resistance against bacterial sepsis corresponds with diverse corticotropin releasing hormone receptor expression by pulmonary CD11c+ MHC II+ and CD11c- MHC II+ APCs.

Authors:  Xavier F Gonzales; Aniket Deshmukh; Mark Pulse; Khaisha Johnson; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2007-12-31       Impact factor: 7.217

7.  The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection.

Authors:  S Nakayama; H Gewurz; T Holzer; T W Du Clos; C Mold
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

8.  CRP and neutrophils: functional effects and complex uptake.

Authors:  E G Shephard; R Anderson; A F Strachan; S H Kühn; F C De Beer
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

9.  The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection.

Authors:  Toh B Gang; David J Hammond; Sanjay K Singh; Donald A Ferguson; Vinod K Mishra; Alok Agrawal
Journal:  J Biol Chem       Date:  2012-11-08       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.